David Kritchevsky

DAVID KRITCHEVSKY, Institute professor, Wistar Institute, Philadelphia, and Emeritus professor of biochemistry in surgery, University of Pennsylvania School of Medicine, Philadelphia "THE SCIENTIST is as basic a resource to me as the Wall Street Journal is to the banker. The rest of the journals keep me informed about my specialty areas. THE SCIENTIST tells me about my world." David Kritchevsky has conducted pioneering research on the role of fat and calories in the development of cancer. Ha

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

DAVID KRITCHEVSKY,
Institute professor, Wistar Institute, Philadelphia, and Emeritus professor of biochemistry in surgery, University of Pennsylvania School of Medicine, Philadelphia

"THE SCIENTIST is as basic a resource to me as the Wall Street Journal is to the banker. The rest of the journals keep me informed about my specialty areas. THE SCIENTIST tells me about my world."

David Kritchevsky has conducted pioneering research on the role of fat and calories in the development of cancer. Having switched from organic chemistry to biochemistry,he wrote the first major book on the metabolism of cholesterol and has demonstrated the different roles of saturated and unsaturated fats in atherosclerosis. He is currently undertaking a comprehensive look at how dietary interactions among nutrients might relate to degenerative disease.

Kritchevsky has served as president of the American Institute of Nutrition and the Society of Experimental Biology and Medicine. His many contributions have most recently been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies